Literature DB >> 29327033

Disorganization of Inner Retina and Outer Retinal Morphology in Diabetic Macular Edema.

Radha Das1, Gareth Spence2, Ruth E Hogg1, Michael Stevenson1, Usha Chakravarthy1.   

Abstract

Importance: In diabetic macular edema (DME), identification of baseline markers on spectral-domain optical coherence tomography (SD-OCT) and their association with severity of diabetic retinopathy (DR) might aid in disease management and the design of future trials. Objective: To examine associations between DR severity, retinal morphology on SD-OCT, and visual acuity in participants with DME. Design, Setting, and Participants: This cross-sectional observational case series was conducted at a single tertiary care referral center. Demographics, visual acuity, SD-OCT, and color fundus photographs of 80 individuals with DME (102 eyes) seen between December 28, 2013, and April 30, 2014, were analyzed between May 1 and July 31, 2016. Main Outcomes and Measures: Features captured on SD-OCT and thickness metrics. On SD-OCT we graded type and shape of DME, shape and presence of septae within the intraretinal cystoid abnormalities, presence of hyperreflective dots and foci, integrity of the external limiting membrane and ellipsoid zone, presence and extent of disorganization of the inner retinal layers (DRIL), and the status of the vitreomacular interface and epiretinal membrane. We measured retinal thickness at the fovea and at the site of maximum pathology, choroidal thickness at the fovea, and 1000 μm temporal and nasal to the fovea. Color photographs were graded to derive a DR severity stage.
Results: The mean (SD) age was 63 (11) years, and 30 participants (37.5%) were women. The odds of having DRIL were greater in eyes with disrupted external limiting membrane (odds ratio [OR], 4.4; 95% CI, 1.6-12.0; P = .003), disrupted ellipsoid zone (OR, 2.7; 95% CI, 1.0-7.2; P = .03), presence of epiretinal membrane (OR, 2.8; 95% CI, 1.0-7.4; P = .03), and increase in retinal thickness at the fovea (OR, 1.6; 95% CI, 1.1-2.2; P < .001). Occurrence of DRIL was more likely in eyes with proliferative DR (OR, 7.3; 95% CI, 1.7-31.4; P = .007). Mean visual acuity decreased by approximately 4.7 letters for each 100-μm increase in the average global DRIL (95% CI, -7.9 to 1.4; P = .006). Conclusions and Relevance: An association was found between DRIL and disruption of the outer retina and increasing DR severity. Further longitudinal studies seem warranted to determine whether DRIL is a clinically relevant noninvasive morphological marker in eyes with DME.

Entities:  

Mesh:

Year:  2018        PMID: 29327033      PMCID: PMC5838716          DOI: 10.1001/jamaophthalmol.2017.6256

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  23 in total

1.  The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema.

Authors:  Anjali S Maheshwary; Stephen F Oster; Ritchie M S Yuson; Lingyun Cheng; Francesca Mojana; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-05-10       Impact factor: 5.258

2.  Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.

Authors:  Arnd Gandorfer; Matthias Rohleder; Sabine Grosselfinger; Christos Haritoglou; Michael Ulbig; Anselm Kampik
Journal:  Am J Ophthalmol       Date:  2005-04       Impact factor: 5.258

3.  Foveal cone outer segment tips line and disruption artifacts in spectral-domain optical coherence tomographic images of normal eyes.

Authors:  Tosho Rii; Yuji Itoh; Makoto Inoue; Akito Hirakata
Journal:  Am J Ophthalmol       Date:  2011-10-21       Impact factor: 5.258

4.  The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema.

Authors:  Hisham Alkuraya; Dustan Kangave; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2006-10-25       Impact factor: 2.031

5.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

7.  Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.

Authors:  Farzin Forooghian; Paul F Stetson; Scott A Meyer; Emily Y Chew; Wai T Wong; Catherine Cukras; Catherine B Meyerle; Frederick L Ferris
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

8.  Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.

Authors:  Jennifer K Sun; Michael M Lin; Jan Lammer; Sonja Prager; Rutuparna Sarangi; Paolo S Silva; Lloyd Paul Aiello
Journal:  JAMA Ophthalmol       Date:  2014-11       Impact factor: 7.389

9.  Cystoid macular edema.

Authors:  Tryfon G Rotsos; Marilita M Moschos
Journal:  Clin Ophthalmol       Date:  2008-12

10.  Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema.

Authors:  Jennifer K Sun; Salma H Radwan; Ahmed Z Soliman; Jan Lammer; Michael M Lin; Sonja G Prager; Paolo S Silva; Lloyd Bryce Aiello; Lloyd Paul Aiello
Journal:  Diabetes       Date:  2015-01-29       Impact factor: 9.461

View more
  43 in total

1.  Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.

Authors:  Murilo W Rodrigues; José A Cardillo; André Messias; Rubens C Siqueira; Ingrid U Scott; Rodrigo Jorge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-23       Impact factor: 3.117

2.  Dilated retinal large vessels and capillaries associated with diabetic macular edema and photoreceptor loss respectively.

Authors:  Jianqin Lei; Xiayu Xu; Li Chen; Xiaojuan Fan; Nizar Saleh Abdelfattah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-08       Impact factor: 3.117

3.  The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography.

Authors:  Fares Antaki; Razek Georges Coussa; Mikel Mikhail; Cyril Archambault; David E Lederer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-07-16       Impact factor: 3.117

Review 4.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

5.  Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.

Authors:  Justis P Ehlers; Atsuro Uchida; Ming Hu; Natalia Figueiredo; Peter K Kaiser; Jeffrey S Heier; David M Brown; David S Boyer; Diana V Do; Andrea Gibson; Namrata Saroj; Sunil K Srivastava
Journal:  Ophthalmol Retina       Date:  2019-07-06

6.  Joint Diabetic Macular Edema Segmentation and Characterization in OCT Images.

Authors:  Joaquim de Moura; Gabriela Samagaio; Jorge Novo; Pablo Almuina; María Isabel Fernández; Marcos Ortega
Journal:  J Digit Imaging       Date:  2020-10       Impact factor: 4.056

7.  Long-term natural history of idiopathic epiretinal membranes with good visual acuity.

Authors:  Kieu-Yen Luu; Tynisha Koenigsaecker; Amirfarbod Yazdanyar; Lekha Mukkamala; Blythe P Durbin-Johnson; Lawrence S Morse; Ala Moshiri; Susanna S Park; Glenn Yiu
Journal:  Eye (Lond)       Date:  2019-04-19       Impact factor: 3.775

8.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

9.  Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.

Authors:  Hassan Khojasteh; Hamid Riazi-Esfahani; Elias Khalili Pour; Hooshang Faghihi; Fariba Ghassemi; Fatemeh Bazvand; Raziyeh Mahmoudzadeh; Mirataollah Salabati; Masoud Mirghorbani; Mohammad Riazi Esfahani
Journal:  Int Ophthalmol       Date:  2019-11-11       Impact factor: 2.031

Review 10.  Artificial intelligence in OCT angiography.

Authors:  Tristan T Hormel; Thomas S Hwang; Steven T Bailey; David J Wilson; David Huang; Yali Jia
Journal:  Prog Retin Eye Res       Date:  2021-03-22       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.